Anavex Life Sciences (AVXL) Earnings Date, Estimates & Call Transcripts $8.35 -0.33 (-3.80%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$8.32 -0.03 (-0.36%) As of 02/21/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Anavex Life Sciences Latest Earnings SummaryUpcoming Q2 Earnings DateMay. 8Before Market OpensEstimatedActual EPS (Feb. 12) -$0.14 Beat By $0.03 Consensus EPS (Feb. 12) -$0.17 Anavex Life Sciences issued Q1 2025 earnings on February 12, 2025, reporting an EPS of -$0.14, which beat the consensus estimate of -$0.17 by $0.03. With a trailing EPS of -$0.55, Anavex Life Sciences' earnings are expected to grow next year, from ($0.69) to ($0.66) per share. Conference CallConference Call TranscriptAVXL Upcoming EarningsAnavex Life Sciences' next earnings date is estimated for Thursday, May 8, 2025, based off prior year's reporting schedules. Get Anavex Life Sciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anavex Life Sciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAVXL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AVXL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Anavex Life Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.17-$0.17-$0.17Q2 20251-$0.16-$0.16-$0.16Q3 20251-$0.18-$0.18-$0.18Q4 20251-$0.20-$0.20-$0.20FY 20254-$0.71-$0.71-$0.71Q1 20261-$0.18-$0.18-$0.18Q2 20261-$0.17-$0.17-$0.17Q3 20261-$0.16-$0.16-$0.16Q4 20261-$0.15-$0.15-$0.15FY 20264($0.66)($0.66)($0.66) Anavex Life Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------2/12/2025Q1 2025-$0.17-$0.14+$0.03-$0.14--12/23/2024Q4 2024-$0.17-$0.14+$0.03-$0.14--8/6/2024Q3 2024-$0.15-$0.14+$0.01-$0.14--5/9/2024Q2 2024-$0.13-$0.13--$0.13--2/7/2024Q1 2024-$0.15-$0.11+$0.04-$0.11--11/27/2023Q3 2023-$0.16-$0.12+$0.04-$0.12--8/8/2023Q3 2023-$0.17-$0.14+$0.03-$0.14--5/9/2023Q2 2023-$0.18-$0.17+$0.01-$0.17-- Anavex Life Sciences Earnings - Frequently Asked Questions When is Anavex Life Sciences's earnings date? Anavex Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on AVXL's earnings history. Did Anavex Life Sciences beat their earnings estimates last quarter? In the previous quarter, Anavex Life Sciences (NASDAQ:AVXL) reported ($0.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.17) by $0.03. Learn more on analysts' earnings estimate vs. AVXL's actual earnings. How can I listen to Anavex Life Sciences's earnings conference call? The conference call for Anavex Life Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Anavex Life Sciences's conference call transcript? The conference call transcript for Anavex Life Sciences's latest earnings report can be read online. Read Transcript How much profit does Anavex Life Sciences generate each year? Anavex Life Sciences (NASDAQ:AVXL) has a recorded net income of -$43 million. AVXL has generated -$0.55 earnings per share over the last four quarters. What is Anavex Life Sciences's EPS forecast for next year? Anavex Life Sciences's earnings are expected to grow from ($0.69) per share to ($0.66) per share in the next year. More Earnings Resources from MarketBeat Related Companies MOR Earnings TWST Earnings VCEL Earnings CPRX Earnings MLTX Earnings MRUS Earnings BEAM Earnings IBRX Earnings ARWR Earnings EWTX Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Hims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead? This page (NASDAQ:AVXL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anavex Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anavex Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
